Comparison of captopril and ibopamine in mild to moderate heart failure

Heart

Volumn 78, Issue 3, 1997, Pages 285-290

  Dohmen, H J M ^a   Dunselman, P H J M ^b   Poole Wilson, P A ^c  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b Ignatius Hospital   (Netherlands)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Captopril; Clinical trials; Heart failure; Ibopamine

Indexed keywords

ALDOSTERONE; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; DIGITALIS; DIGOXIN; DIURETIC AGENT; IBOPAMINE; NEUROHORMONE; NORADRENALIN; PLACEBO; RENIN;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPNEA; EUROPE; EXERCISE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030879342     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.3.285     Document Type: Article

References (20)

1. Packer M. How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease. Am J Cardiol 1993;71: 3-11C.
2. Grinstead WC, Francis MJ, Marks GF, Tawa CB, Zoghbi WA, Young JB. Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. Am J Cardiol 1994;73:881-6.
3. Braunwald E. ACE inhibitors: a cornerstone of the treatment of heart failure. N Engl J Med 1991;325:351-3.
4. Henwood JM, Todd PA. Ibopamine: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 1988;36:11-31.
5. Rousseau MF, Raigoso J, van Eyll C. Effects of intravenous epinine administration on left ventricular systolic performance, coronary hemodynamics, and circulating catecholamines in patients with heart failure. J Cardiovasc Pharmacol 1992;19:155-62.
6. van Veldhuisen DJ, Man in 't Veld AJ, Dunselman PHJM, Lok DJA, Dohmen HJM, Poortermans JC, et al. Double-blind placebo controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). J Am Coll Cardiol 1993;22:1564-73.
7. Cavalli A, Riva E, Schleman M, Abbondati G, Fuccella LM. Ibopamine as a substitute for digitalis in patients on chronic digoxin therapy. Int J Cardiol 1989;22:381-7.
8. Kleber FX, Thyroff-Friesinger U. Ibopamine versus digoxin in the treatment of mild congestive heart failure. Cardiology 1990;77(suppl 5):75-80.
9. Parker JO, and the Ibopamine Study Group. The effects of oral ibopamine in patients with mild heart failure - a double blind placebo controlled comparison to furosemide. Int J Cardiol 1993;40:221-7.
10. Feinstein AR, Fisher MB, Pigeon JG. Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure. Am J Cardiol 1989;64: 50-5.
11. Barabino A, Galbariggi G, Pizzorni C, Lotti G. Comparative effects of long term therapy with captopril and ibopamine in chronic congestive heart failure in old patients. Cardiology 1991;78:243-56.
12. Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol 1983;2:755-63.
13. Cohn JN. The prevention of heart failure - a new agenda. N Engl J Med 1992;327:725-7.
14. Erhardt L, MacLean A, Ilgenfritz JP, Gelperin K, Blumenthal M. Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Eur Heart J 1995;16:1892-9.
15. Brown EJ, Chew PH, MacLean A, Gelperin K, Ilgenfri JP, Blumenthal M. Effects of fosinopril on exercise tole. ance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Am J Cardiol 1995;75:596-600.
16. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316: 1429-35.
17. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325: 293-302.
18. Pfeffer MA, Braunwald E, Moye LA. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669-77.
19. van Veldhuisen DJ, Brouwer J, Man in 't Veld AJ, Dunselman PHJM, Boomsma F. Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. Am J Cardiol 1995;75: 796-800.
20. Hampton JR. Prospective randomised study of ibopamine on mortality and efficacy in heart failure (PRIME II). Presented at the 45th Annual Scientific Sessions of the American College of Cardiology, Orlando, Florida, USA, 25 March 1996.